Suppr超能文献

2型糖尿病的特定病因死亡率。维罗纳糖尿病研究。

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.

作者信息

de Marco R, Locatelli F, Zoppini G, Verlato G, Bonora E, Muggeo M

机构信息

Division of Medical Statistics, University of Verona, Medical School, Italy.

出版信息

Diabetes Care. 1999 May;22(5):756-61. doi: 10.2337/diacare.22.5.756.

Abstract

OBJECTIVE

This population-based study, carried out in the framework of the Verona Diabetes Study, investigated mortality from specific causes in known type 2 diabetic patients.

RESEARCH DESIGN AND METHODS

A cohort of 7,148 known type 2 diabetic patients (3,366 men and 3,782 women) was identified on 31 December 1986 and followed up for 5 years (1987-1991). Underlying causes of death were obtained from death certificates and were coded according to the International Classification of Diseases, Ninth Revision. Cause-specific death rates of diabetic subjects were compared with those of the inhabitants of Verona. By 31 December 1991, 1,550 diabetic subjects (744 men and 806 women) had died.

RESULTS

The standardized mortality ratio (SMR) for all causes of death was 1.42 (95% CI 1.35-1.50). The highest SMRs were for the following specific causes: diabetes (SMR 4.47 [3.91-5.10]), gastrointestinal diseases (1.83 [1.50-2.21])--particularly liver cirrhosis (2.52 [1.96-3.20])--and cardiovascular diseases (1.34 [1.23-1.44]), particularly cerebrovascular (1.48 [1.25-1.73]) and ischemic heart diseases (1.41 [1.24-1.62]). A significantly higher than expected risk of mortality for cardiovascular causes was already present in the first 5 years after diagnosis and decreased with age. Type 2 diabetic patients treated with insulin had a higher risk of dying than those treated orally or by diet.

CONCLUSIONS

The highest SMRs in the diabetic cohort were for diabetes and liver cirrhosis. The mortality risk for cardiovascular diseases, although significantly higher than expected, was much lower in Italian type 2 diabetic patients than that reported for American patients. The evidence of an early effect on mortality suggests that prevention, early diagnosis, and treatment should be improved.

摘要

目的

这项基于人群的研究在维罗纳糖尿病研究框架内开展,调查了已知2型糖尿病患者的特定病因死亡率。

研究设计与方法

1986年12月31日确定了一组7148例已知2型糖尿病患者(3366名男性和3782名女性),并随访5年(1987 - 1991年)。死亡的根本原因从死亡证明中获取,并根据国际疾病分类第九版进行编码。将糖尿病患者的特定病因死亡率与维罗纳居民的死亡率进行比较。到1991年12月31日,1550例糖尿病患者(744名男性和806名女性)死亡。

结果

所有死因的标准化死亡率(SMR)为1.42(95%可信区间1.35 - 1.50)。以下特定病因的SMR最高:糖尿病(SMR 4.47 [3.91 - 5.10])、胃肠道疾病(1.83 [1.50 - 2.21])——尤其是肝硬化(2.52 [1.96 - 3.20])——以及心血管疾病(1.34 [1.23 - 1.44]),尤其是脑血管疾病(1.48 [1.25 - 1.73])和缺血性心脏病(1.41 [1.24 - 1.62])。诊断后的前5年中,心血管病因导致的死亡风险就已显著高于预期,且随年龄降低。接受胰岛素治疗的2型糖尿病患者比接受口服治疗或饮食治疗的患者死亡风险更高。

结论

糖尿病队列中最高的SMR是糖尿病和肝硬化。心血管疾病的死亡风险虽然显著高于预期,但意大利2型糖尿病患者的这一风险远低于美国患者报告的风险。对死亡率有早期影响的证据表明应改进预防、早期诊断和治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验